Christopher Alvarez-Breckenridge
Affiliations: | Ohio State University, Columbus, Columbus, OH |
Google:
"Christopher Alvarez-Breckenridge"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nguyen TT, Shin DH, Sohoni S, et al. (2022) Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. Journal For Immunotherapy of Cancer. 10 |
| Alvarez-Breckenridge C, Markson S, Stocking J, et al. (2020) IMMU-01. SINGLE CELL SEQUENCING OF MELANOMA BRAIN METASTASES UNVEILS HETEROGENEITY OF THE TUMOR MICROENVIRONMENT IN RESPONSE TO IMMUNE CHECKPOINT BLOCKADE Neuro-Oncology. 22: ii104-ii104 |
| Brastianos PK, Alvarez-Breckenridge C, Miller JJ, et al. (2017) OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor Neuro-Oncology. 19: iii11-iii11 |
| Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, et al. (2016) BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Suryadevara CM, Gedeon PC, Sanchez-Perez L, et al. (2015) Are BiTEs the "missing link" in cancer therapy? Oncoimmunology. 4: e1008339 |
| Alvarez-Breckenridge CA, Choi BD, Suryadevara CM, et al. (2015) Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection. Current Opinion in Virology. 13: 25-32 |
| Alvarez-Breckenridge CA, Choi BD, Suryadevara CM, et al. (2015) Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection Current Opinion in Virology. 13: 25-32 |
| Kaur B, Meisen WH, Hardcastle J, et al. (2014) Vstat120 Reduces The Innate Inflammatory Response To Infection And Enhances Oncolytic Viral Therapy For Glioblastoma. Neuro-Oncology. 16 |
| Alvarez-Breckenridge CA, Yu J, Caligiuri MA, et al. (2013) Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy. Oncoimmunology. 2: e23658 |
| Price RL, Song J, Bingmer K, et al. (2013) Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Research. 73: 3441-50 |